Since it is taken once a week, it is easier to fit it into your routine
FDA approvals happened in: Saxenda: December 2014 Wegovy: June 2021 Zepbound: November 2023 Increased focus on metabolic health: Rising rates of obesity, diabetes, and cardiac diseasescombined with more awareness of obesity as a chronic condition as opposed to a moral failingshifted the conversation from just willpower to effective treatment options
Mechanism of Action: The Science Behind the Dual Agonism Amycretin is a single peptide engineered from two covalently linked analogs one derived from GLP-1, one from amylin
Mas G, Man N, Nakata Y, Martinez-Caja C, Karl D, Beckedorff F, et al
Relationships between oesophageal transit and solid and liquid gastric emptying in diabetes mellitus
Alogliptin did not increase the risk of gastrointestinal problems, fracture or cancer in T2DM patients